Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Oncotelic Therapeutics, Inc. (MATN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -9.4-9.5-6.6-0.7-13.8-13.7-13.7-12.6
Depreciation and amortization   [+]0.10.40.10.00.00.00.00.1
Stock-based compensation  0.82.10.30.10.80.80.80.4
Change in working capital   [+]0.30.51.10.12.0-2.40.90.0
Other operating activities  3.83.62.90.3    
Cash from operations  -4.4-2.8-2.3-0.2-10.9-15.2-11.9-12.2
   
Capital expenditures  0.00.00.00.00.00.00.00.0
Purchases of short-term investments, net       -8.5  
Other cash from investing    0.2 8.5   
Cash from investing  0.00.00.20.08.5-8.50.00.0
   
Issuance of common stock, net  2.02.90.10.2  9.225.7
Other cash from financing  2.60.32.1    9.5
Cash from financing  4.53.22.20.20.00.09.235.2
   
Free cash flow  -4.4-2.8-2.3-0.2-10.9-15.2-11.9-12.2
        Per share (diluted)  ($0.01)($0.03)($0.04)($0.04)($0.41)($0.57)($0.47)($0.72)
   
Cash paid for interest  0.30.1      
Cash paid for income taxes  0.00.0      

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy